How well does a new lung cancer medication work in real patients

This trial is testing lorlatinib, an oral medication taken as a daily pill, in people with a specific type of advanced lung cancer that has not been treated before. Researchers want to understand how well this treatment works and how safe it is when used in real-world medical settings in France, rather than in tightly controlled research conditions.

This medication has shown promise in clinical trials, but researchers want to see how it performs in everyday practice when used by a broader range of patients and in typical hospital or clinic settings, to better understand its real-world benefits and any side effects people might experience.